Equity · Healthcare
SANA
NASDAQSana Biotechnology (SANA)
The line runs 3.79 USD on 12 August through 2.47 USD on 9 November, on a scale from 2 to 5. Days the market did not trade hold the previous close, flat.
- Market cap
- 740.1M USD
- EPS, diluted, year to Dec 2025
- −0.96 USD
- 52-week range
- 2.28 USD – 5.20 USD
- Avg volume
- 223.0K
- Mentions, 30 days
- 2
as of Nov 9, 2026
Have Sana Biotechnology (SANA) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, no Sana Biotechnology insider bought or sold shares on the open market; all 3 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
Form 4, 90 days to 10 Nov 2026, newest Form 4 filing 5 Oct 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 05 Oct 2026 | Bishop Hans EdgarDirector | Award | 8,680 | |
| 27 Aug 2026 | PATEL DHAVALKUMAR DHIRAJLALEVP, Chief Scientific Officer | Tax withheld | 41,158 | 169K USD |
| 26 Aug 2026 | PATEL DHAVALKUMAR DHIRAJLALEVP, Chief Scientific Officer | Option exercise | 125,000 |
Which funds hold Sana Biotechnology (SANA)?
10 of the 45 institutional funds we track reported a Sana Biotechnology position for the quarter ended 30 Jun 2026 — a combined 26.6M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Marshall Wace | Added | 2,931,436 | 10.2M USD | +341.2% |
| Renaissance Technologies | Held (±25%) | 1,231,100 | 4.3M USD | −15.2% |
| AQR Capital Management | Held (±25%) | 963,147 | 3.4M USD | −14.3% |
| Millennium Management | Trimmed | 653,503 | 2.3M USD | −58.9% |
| Two Sigma Investments | Trimmed | 638,837 | 2.2M USD | −46.7% |
| Point72 Asset Management | New position | 595,091 | 2.1M USD | |
| Baker Bros. Advisors | Held (±25%) | 310,483 | 1.1M USD | |
| Citadel Advisors | Trimmed | 161,178 | 563K USD | −71.7% |
| Tudor Investment Corp | Trimmed | 87,892 | 307K USD | −34.0% |
| D. E. Shaw & Co. | Held (±25%) | 40,090 | 140K USD | +3.7% |
What has been filed or recorded for Sana Biotechnology (SANA)?
The filings we hold for Sana Biotechnology, newest first: 1 fails-to-deliver day, 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.07 USD | |
| 30 Sep 2026 | Financials | Total assets | 376.1M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 180.4M USD | at period end |
| 29 Sep 2026 | Fails to deliver | Shares failed to deliver | 320 shares | 938 USD notional · <0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.22 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.17 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −0.96 USD | |
| 31 Dec 2025 | Financials | Net income | −244.2M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −0.96 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.16 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.39 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.21 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −1.16 USD |
What is Reddit saying about Sana Biotechnology (SANA)?
Reddit mentioned SANA 2 times in the 30 days to 10 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 50% read bullish, 0% bearish and 50% neither. Reddit data updated 10 November 2026.
30-day window, Method
How do Reddit mentions of Sana Biotechnology (SANA) compare with its price?
Share ↗
Which subreddits are talking about Sana Biotechnology (SANA)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/stocks | 100% | 2 | +0.07 |
What do people ask about Sana Biotechnology (SANA)?
What did Sana Biotechnology shares close at?2.47
Sana Biotechnology closed at 2.47 USD on 9 Nov 2026, up 5.11% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Sana Biotechnology’s market cap?740.1M
Sana Biotechnology is worth 740.1M USD by market value as of 9 Nov 2026, which is the share price times the shares on issue from its SEC filings.
Have Sana Biotechnology insiders bought or sold shares recently?3 filings
In the 90 days to 10 Nov 2026, no Sana Biotechnology insider bought or sold shares on the open market; all 3 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4). See Insiders
Which funds own Sana Biotechnology?10 of 45
10 of the 45 funds we track reported a Sana Biotechnology position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Marshall Wace, Renaissance Technologies and AQR Capital Management. See Funds
When did Sana Biotechnology last report earnings?0.07
Sana Biotechnology last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.07 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Sana Biotechnology?0 mentions
Sana Biotechnology was mentioned 0 times in the last 7 days across the finance subreddits we track, and 2 times over the trailing 30 days. Of the 2 mentions scored for sentiment, 50% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings